Urinary Tract Infections (UTIs) affect more than 152 million patients yearly and are, therefore, one of the most common types of diseases. Diagnostics of UTIs require time-consuming sample logistics and incubation by specialists in laboratories with high personnel costs (duration: 2-5 working days). As an initial treatment, patients are prescribed a broad-spectrum antibiotic until a more accurate infection assessment is available, leading to the development of multi-resistant germs. BugSense is a paper-based, patient-oriented solution combining cultivation and antibiotic resistance testing in one step, reducing testing time, costs, logistical effort, and especially unnecessary antibiotic prescriptions. The test should provide a user-friendly diagnostic and personalized treatment for anyone.
Company Details
- Employees
- 10
- Address
- München , Bayern 81675, De
- Industry
- Biotechnology
- Website
- https://www.bugsensedx.com/
- Keywords
- POCT, Diagnostics, UTIs.
- HQ
- München , Bayern
Bugsense Diagnostics Questions
Bugsense Diagnostics's website is https://www.bugsensedx.com/
Bugsense Diagnostics's LinkedIn profile is https://de.linkedin.com/company/bugsense-diagnostics
Bugsense Diagnostics has
10 employees.
View email and phone details for 10
employees at Bugsense Diagnostics.
Bugsense Diagnostics's industry is
Biotechnology
Bugsense Diagnostics's top competitors are
Echoscout,
Bugsense,
Tengable,
Medical Innovations Incubator Gmbh,
Omicsdiscoveries,
Sorealert,
Heartbeat Medical,
Cellnroll,
Selphspace,
Sigma Squared Society.
Bugsense Diagnostics's categories are Biotechnology
